C4 Therapeutics Inc. (CCCC)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
3. 69
+0.11
+3.0726%
$
315.57M Market Cap
- P/E Ratio
- Div Yield
2.46M Volume
-1.85 Eps
$ 3.58
Previous Close 
Want to track CCCC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
C4 Therapeutics Inc. (CCCC) Statistics
Valuation metrics
Market Cap 315.57M
Enterprise value 302.81M
Trailing P/E (ttm) -3.1
Forward P/E -
PEG ratio -0.19
Price/Sales (ttm) 8.77
Price/Book (mrq) 1.99
Enterprise Value/Revenue 8.69
Enterprise Value/EBITDA -3.02
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.31M
Average volume (90 days) 3.16M
Price summary
52-Week low 1.69
52-Week high 5.17
Beta -
50-Day moving average 4.05
200-Day moving average 2.7
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.98%
Operating margin -3.27%
Operational effectiveness
Return on assets -0.32%
Return on equity -0.51%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.28
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.82
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.87
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 9%
Book value per share (mrq) 1.86
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
